Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) EBIT Margin: 2009-2024

Historic EBIT Margin for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to 3.41%.

  • Pediatrix Medical's EBIT Margin rose 71900.0% to 13.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.37%, marking a year-over-year increase of 213000.0%. This contributed to the annual value of 3.41% for FY2024, which is 37800.0% down from last year.
  • Pediatrix Medical's EBIT Margin amounted to 3.41% in FY2024, which was down 37800.0% from 0.37% recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's EBIT Margin ranged from a high of 10.62% in FY2021 and a low of 3.41% during FY2024
  • Moreover, its 5-year median value for EBIT Margin was 5.66% (2020), whereas its average is 4.4%.
  • As far as peak fluctuations go, Pediatrix Medical's EBIT Margin soared by 49600bps in 2021, and later tumbled by -83900bps in 2023.
  • Pediatrix Medical's EBIT Margin (Annual) stood at 5.66% in 2020, then surged by 88bps to 10.62% in 2021, then decreased by -18bps to 8.76% in 2022, then crashed by -96bps to 0.37% in 2023, then crashed by -1030bps to 3.41% in 2024.
  • Its EBIT Margin was 3.41% in FY2024, compared to 0.37% in FY2023 and 8.76% in FY2022.